Quorum Health Corporation (NYSE:QHC) enjoyed a 125.26% run-up in share price since hitting record low of $0.95. The stock managed 3.88% rise and now stands at $2.14 as of 5/24/2019. At a recent session, the prices were hovering between $2.04 and $2.15. This company shares are 110.28% off its target price of $4.5 and the current market capitalization stands at $64.39M. The recent change has given its price a 28.59% lead over SMA 50 and -65.76% deficit over its 52-week high. The stock witnessed 30.49% gains, -19.55% declines and -45.82% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found QHC’s volatility during a week at 8.56% and during a month it has been found around 12.23%.

Quorum Health Corporation (QHC) Top Holders

Institutional investors currently hold around $57 million or 90.1% in QHC stock. Look at its top three institutional owners: Goldman Sachs Group Inc owns $6.43 million in Quorum Health Corporation, which represents roughly 9.98% of the company’s market cap and approximately 11.27% of the institutional ownership. Similar statistics are true for the second largest owner, Kohlberg Kravis Roberts & Co. L.P., which owns 2,988,781 shares of the stock are valued at $6.4 million. The third largest holder is York Capital Management Global Advisors, Llc, which currently holds $6.38 million worth of this stock and that ownership represents nearly 9.9% of its market capitalization.

Quorum Health Corporation 13F Filings

At the end of March reporting period, 43 institutional holders increased their position in Quorum Health Corporation (NYSE:QHC) by some 3,176,185 shares, 63 decreased positions by 5,626,259 and 25 held positions by 17,984,220. That puts total institutional holdings at 26,786,664 shares, according to SEC filings. The stock grabbed 20 new institutional investments totaling 934,502 shares while 29 institutional investors sold out their entire positions totaling 1,326,119 shares.

Quorum Health Corporation (NYSE:QHC) Insider Trades

Multiple company employees have indulged in significant insider trading. Quorum Health Corporation disclosed in a document filed with the US Securities and Exchange Commission (SEC) that SVP and Chief Medical Officer Koury Shaheed has acquired 10,000 shares of Quorum Health Corporation (QHC) in the trading session dated Nov. 13, 2017. These shares are worth $46,900 and were traded at $4.69 each. The SEC filing shows that Koury Shaheed performed a purchase of 8,500 shares. The SVP and Chief Medical Officer added these shares by way of transaction on May. 25, 2017. The company’s shares were assimilated at $3.56 per share worth to an investment of some $30,260 to the account of Koury Shaheed.

President and CEO, Miller Thomas Daniel, purchased 185,000 common shares of Quorum Health Corporation (QHC) in the open market. In a transaction dated May. 18, 2017, the shares were bought at an average price of $2.85, giving away a sum of $527,250. After this purchase, 814,139 common shares of QHC are directly owned by the insider, with total stake valued at $1,742,258.

In the transaction dated May. 18, 2017, a great number of shares acquired came courtesy the SVP and Chief Medical Officer; Koury Shaheed added a total of 10,000 shares at an average price of $2.72, amounting to approximately $27,200. The insider now directly owns 80,180 shares worth $171,585.

Quorum Health Corporation (QHC) Analyst Guide

Several analysts have released their opinion on Quorum Health Corporation (NYSE:QHC), with 0 analysts believing it is a strong buy. Whereas 2 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 3 average brokerage recommendation [T1].